Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial

• Al-Khatib, S.M.
• Pieper, K.S.
• Lee, K.L.
• Mahaffey, K.W.
• Hochman, J.S.
• Pepine, C.J.
• Kopecky, S.
• Stepinska, J.
• Simoons, M.L.
• Topol, E.J.
• Califf, R.M.
• Harrington, R.A.
• Akkerhuis, K.M.
• , et al.

July 2001
Article

Related Files
Redirect to publisher's version (publisher's version.url.txt, 47 bytes)

• Male
• Human
• Female
• Survival Analysis
• Treatment Outcome
• Support
• Platelet Aggregation Inhibitors/therapeutic use
• Double-Blind Method
• Cerebrovascular Accident/etiology/mortality
• 0 (Peptides)
• Non-U.S. Gov't
• Peptides/therapeutic use
• 0 (Platelet Aggregation Inhibitors)
• 0 (eptifibatide)
• Atrial Fibrillation/drug therapy/*etiology/*mortality
• Hazards Models
• Myocardial Ischemia/*complications/drug therapy